Mar 12, 2019
FDA approves a new generic valsartan
Mar 09, 2019
Information Update - Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
Mar 01, 2019
FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall
Nov 28, 2018
Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity
Nov 08, 2018
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)
Oct 04, 2018
ANI Pharmaceuticals Announces Launch of Authorized Generic of Atacand HCT® Tablets
Sep 13, 2018
FDA provides update on its ongoing investigation into valsartan products; and reports on the finding of an additional impurity identified in one firm's already recalled products
Sep 06, 2018
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to product/label mix-up
Aug 20, 2018
/R E P E A T -- Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution/
Jul 10, 2018
Update - Advisory - Several drugs containing valsartan being recalled due to contamination with a potential carcinogen
Jul 09, 2018
Advisory - Several drugs containing valsartan being recalled due to contamination with a potential carcinogen
Aug 01, 2017
Daiichi Sankyo Announces Settlement Agreement on U.S. Products Liability Litigation